NasoShield Study of Safety and Immunogenicity

Clinical trial NCT03352466 · COMPLETED

Trial details

NCT number: NCT03352466
Sponsor: Altimmune, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2018-01-18
Primary completion: 2019-05-13
Enrollment: 145

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.